Back
Health Catalyst Vs. OptimizeRx Industry Stock Comparison
Buy
61
HCAT
Health Catalyst
Last Price:
8.51
Seasonality Move:
3.26%
Sell
22
OPRX
OptimizeRx
Last Price:
4.98
Seasonality Move:
11.57%
Buy
61
Health Catalyst (HCAT)
is a Buy
Is Health Catalyst a Buy, Sell or Hold?
- The current Health Catalyst [HCAT] share price is $8.52. The Score for HCAT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- HCAT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
22
OptimizeRx (OPRX)
is a Sell
Is OptimizeRx a Buy, Sell or Hold?
- The current OptimizeRx [OPRX] share price is $4.65. The Score for OPRX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- OPRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HCAT Stock Price Chart
What is Health Catalyst's stock price today?
-
The Health Catalyst share price today is $8.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HCAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
OPRX Stock Price Chart
What is OptimizeRx's stock price today?
-
The OptimizeRx share price today is $4.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OPRX is experiencing selling pressure, which indicates risk of future bearish movement.
HCAT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 57 | Buy |
Chaikin Money Flow: | 296536 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.62 - 8.4) | Buy |
Bollinger Bands (100): | (6.82 - 8.34) | Buy |
OPRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.51 | Sell |
Relative Strength Index (14 RSI): | 41.33 | Sell |
Chaikin Money Flow: | -264270 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.52 - 6) | Sell |
Bollinger Bands (100): | (5.83 - 9.51) | Sell |
HCAT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.86 | Buy |
20-day SMA: | 8.01 | Buy |
50-day SMA: | 8.13 | Buy |
200-day SMA: | 7.34 | Buy |
8-day EMA: | 8 | Buy |
20-day EMA: | 8.01 | Buy |
50-day EMA: | 7.94 | Buy |
200-day EMA: | 7.88 | Buy |
OPRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.32 | Buy |
20-day SMA: | 5.15 | Sell |
50-day SMA: | 6.26 | Sell |
200-day SMA: | 9.89 | Sell |
8-day EMA: | 4.68 | Sell |
20-day EMA: | 5.12 | Sell |
50-day EMA: | 6.1 | Sell |
200-day EMA: | 9 | Sell |
Health Catalyst Earnings Growth & HCAT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.09 per share.
OptimizeRx Earnings Growth & OPRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.07 per share.
Health Catalyst Technical Analysis
Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
OptimizeRx Technical Analysis
Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |